Factors associated with compliance, discontinuation and switching of calcium channel blockers in 20,156 chinese patients

American Journal of Hypertension

Volumn 22, Issue 8, 2009, Pages 904-910

  Wong, Martin C S ^a   Jiang, Johnny Y ^a   Griffiths, Sian M ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE;

ADULT; AGE; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CHINESE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FAMILY MEDICINE; FEMALE; FOLLOW UP; GENDER; HONG KONG; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL FEE; PATIENT COMPLIANCE; PRIORITY JOURNAL;

AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; DATABASES, FACTUAL; FEMALE; HONG KONG; HUMANS; HYPERTENSION; INSURANCE, HEALTH; MALE; MIDDLE AGED; PATIENT COMPLIANCE; SEX FACTORS; TREATMENT OUTCOME;

EID: 68149148160     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2009.95     Document Type: Article

References (38)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217-223.
2. World Health Organization. World Health Report 2002 - Reducing risks, Promoting healthy life. World Health Organization: Geneva, Switzerland, 2002. .
3. Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality in persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group. JAMA 1979; 242: 2562-2571.
4. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991; 265: 3255-3264.
5. Kaplan NM, Flynn JT. Kaplan's Clinical Hypertension, 9th edn. Lippincott Williams & Wilkins: Philadelphia, PA, 2006, pp. 264.
6. Whelton PK, He J, Muntner P. Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia. J Hum Hypertens 2004; 18: 545-551.
7. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, Poulter N, Primatesta P, Stegmayr B, Thamm M. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004; 43: 10-17.
8. Borzecki AM, Oliveria SA, Berlowitz DR. Barriers to hypertension control. Am Heart J 2005; 149: 785-794.
9. Van Wijk BL, Klungel OH, Heerdink ER, de Boer A. Initial non-compliance with antihypertensive monotherapy is followed by complete discontinuation of antihypertensive therapy. Pharmacoepidemiol Drug Saf 2006; 15: 587-593.
10. Taira DA, Wong KS, Frech-Tamas F, Chung RS. Copayment level and compliance with antihypertensive medication: analysis and policy implications for managed care. Am J Manag Care 2006; 12: 678-683.
11. Wannemacher AJ, Schepers GP, Townsend KA. Antihypertensive medication compliance in a Veterans Affairs Healthcare System. Ann Pharmacother 2002; 36: 986-991.
12. Patel BV, Remigio-Baker RA, Mehta D, Thiebaud P, Frech-Tamas F, Preblick R. Effects of initial antihypertensive drug class on patient persistence and compliance in a usual-care setting in the United States. J Clin Hypertens (Greenwich) 2007; 9: 692-700.
13. Jones JK, Gorkin L, Lian JF, Staffa JA, Fletcher AP. Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population. BMJ 1995; 311: 293-295.
14. Burke TA, Sturkenboom MC, Lu SE, Wentworth CE, Lin Y, Rhoads GG. Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice. J Hypertens 2006; 24: 1193-1200.
15. Mazzaglia G, Mantovani LG, Sturkenboom MC, Filippi A, Trifirò G, Cricelli C, Brignoli O, Caputi AP. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care. J Hypertens 2005; 23: 2093-2100.
16. Wong MC. Short- and long-term discontinuation patterns of commonly prescribed antihypertensive drugs among a Chinese population: cohort study. J Hum Hypertens 2008; 22: 435-437.
17. Li WW, Stotts NA, Froelicher ES. Compliance with antihypertensive medication in Chinese immigrants: cultural specific issues and theoretical application. Res Theory Nurs Pract 2007; 21: 236-254.
18. Li WW, Stewart AL, Stotts NA, Froelicher ES. Cultural factors and medication compliance in Chinese immigrants who are taking antihypertensive medications: instrument development. J Nurs Meas 2005; 13: 231-252.
19. Wong MC, Jiang JY, Lam AT, Fung H, Griffiths S, Mercer SW. Patterns of antihypertensive prescribing, discontinuation and switching among a Hong Kong Chinese population from over one million prescriptions. J Hum Hypertens 2008; 22: 714-716.
20. Cheung NT. Realizing the benefits of eHealth in Hong Kong (2006). Accessed 20 January 2009.
21. Wong MC, Jiang JY, Tang JL, Lam A, Fung H, Mercer SW. Health services research in the public healthcare system in Hong Kong: an analysis of over 1 million antihypertensive prescriptions between 2004-2007 as an example of the potential and pitfalls of using routinely collected electronic patient data. BMC Health Serv Res 2008; 8: 138.
22. Population by-census, 2006, Hong Kong Special Administrative Region, China (2006). Accessed 17 May 2009.
23. Halpern MT, Khan ZM, Schmier JK, Burnier M, Caro JJ, Cramer J, Daley WL, Gurwitz J, Hollenberg NK. Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data. Hypertension 2006; 47: 1039-1048.
24. Lee JY, Kusek JW, Greene PG, Bernhard S, Norris K, Smith D, Wilkening B, Wright JT. Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Am J Hypertens 1996; 9: 719-725.
25. Mallion JM, Baguet JP, Siche JP, Tremel F, de Gaudemaris R. Compliance, electronic monitoring and antihypertensive drugs. J Hypertens Suppl 1998; 16: S75-S79.
26. Jackson KC, Sheng X, Nelson RE, Keskinaslan A, Brixner DI. Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database. Clin Ther 2008; 30: 1558-1563.
27. Bautista LE. Predictors of persistence with antihypertensive therapy: results from the NHANES. Am J Hypertens 2008; 21: 183-188.
28. Caro JJ, Salas M, Speckman JL, Raggio G, Jackson JD. Persistence with treatment for hypertension in actual practice. CMAJ 1999; 160: 31-37.
29. Degli Esposti L, Degli Esposti E, Valpiani G, Di Martino M, Saragoni S, Buda S, Baio G, Capone A, Sturani A. A retrospective, population-based analysis of persistence with antihypertensive drug therapy in primary care in Italy. Clin Ther 2000; 24: 1347-1357; discussion 1346.
30. Billups SJ, Malone DC, Carter BL. The relationship between drug therapy noncompliance and patient characteristics, health-related quality of life, and health care costs. Pharmacotherapy 2000; 20: 941-949.
31. Vaur L, Vaisse B, Genes N, Elkik F, Legrand C, Poggi L. Use of electronic pill boxes to assess risk of poor treatment compliance: results of a large-scale trial. Am J Hypertens 1999; 12: 374-380.
32. Vinker S, Alkalay A, Hoffman RD, Elhayany A, Kaiserman I, Kitai E. Long-term adherence to antihypertensive therapy: a survey in four primary care clinics. Expert Opin Pharmacother 2008; 9: 1271-1277.
33. Carter BL. Adherence, quality of life, cost effectiveness, and the role of the pharmacist. In Lip GYH & Hall JE (eds), Comprehensive Hypertension. Elsevier: Philadelphia, PA, 2007, Chapter 92, pp. 1119-1127.
34. Degli Esposti E, Sturani A, Di Martino M, Falasca P, Novi MV, Baio G, Buda S, Volpe M. Long-term persistence with antihypertensive drugs in new patients. J Hum Hypertens 2002; 16: 439-444.
35. Erkens JA, Panneman MM, Klungel OH, van den Boom G, Prescott MF, Herings RM. Differences in antihypertensive drug persistence associated with drug class and gender: a PHARMO study. Pharmacoepidemiol Drug Saf 2005; 14: 795-803.
36. Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 2008; 336: 1114-1117.
37. Ogedegbe G, Mancuso CA, Allegrante JP, Charlson ME. Development and evaluation of a medication adherence self-efficacy scale in hypertensive African-American patients. J Clin Epidemiol 2003; 56: 520-529.
38. Ockene IS, Ockene JK. Barriers to lifestyle change, and the need to develop an integrated approach to prevention. Cardiol Clin 1996; 14: 159-169.